These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genetics of tardive dyskinesia. Lee HJ; Kang SG Int Rev Neurobiol; 2011; 98():231-64. PubMed ID: 21907090 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)]. Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575 [TBL] [Abstract][Full Text] [Related]
5. Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes. Zai CC; Tiwari AK; Basile V; de Luca V; Müller DJ; Voineskos AN; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Kennedy JL Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):50-6. PubMed ID: 19778569 [TBL] [Abstract][Full Text] [Related]
6. [Manganese superoxide dismutase gene (MnSOD) polimorphism in schizophrenics with tardive dyskinesia from central Poland]. Gałecki P; Pietras T; Szemraj J Psychiatr Pol; 2006; 40(5):937-48. PubMed ID: 17217237 [TBL] [Abstract][Full Text] [Related]
7. Oxidative stress and therapeutic implications in psychiatric disorders. Zhang XY; Yao JK Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():197-9. PubMed ID: 23523744 [TBL] [Abstract][Full Text] [Related]
8. Association between the MnSOD Ala-9Val polymorphism and development of schizophrenia and abnormal involuntary movements in the Xhosa population. Hitzeroth A; Niehaus DJ; Koen L; Botes WC; Deleuze JF; Warnich L Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):664-72. PubMed ID: 17291655 [TBL] [Abstract][Full Text] [Related]
9. Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia. Zai CC; Tiwari AK; Mazzoco M; de Luca V; Müller DJ; Shaikh SA; Lohoff FW; Freeman N; Voineskos AN; Potkin SG; Lieberman JA; Meltzer HY; Remington G; Kennedy JL J Psychiatr Res; 2013 Nov; 47(11):1760-5. PubMed ID: 24018103 [TBL] [Abstract][Full Text] [Related]
10. Mn-superoxide dismutase activity is associated with orofacial involuntary movements in schizophrenia patients with tardive dyskinesia. Wu JQ; Chen DC; Tan YL; Soares JC; Zhang XY Hum Psychopharmacol; 2015 Jan; 30(1):57-63. PubMed ID: 25572310 [TBL] [Abstract][Full Text] [Related]
11. Manganese superoxide dismutase gene Ala-9Val polymorphism might be related to the severity of abnormal involuntary movements in Korean schizophrenic patients. Kang SG; Choi JE; An H; Park YM; Lee HJ; Han C; Kim YK; Kim SH; Cho SN; Joe SH; Jung IK; Kim L; Lee MS Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1844-7. PubMed ID: 18790709 [TBL] [Abstract][Full Text] [Related]
12. Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismutase gene (MnSOD: Ala-9Val) polymorphisms on tardive dyskinesia in patients with schizophrenia. Pae CU Psychiatry Res; 2008 Dec; 161(3):336-8. PubMed ID: 18977034 [TBL] [Abstract][Full Text] [Related]
13. [Pro- and antioxidant processes in schizophrenics with tardive dyskinesia]. Gałecki P; Pietras T; Florkowki A Psychiatr Pol; 2005; 39(6):1131-41. PubMed ID: 16526180 [TBL] [Abstract][Full Text] [Related]
14. Cognition impairment in schizophrenia patients with tardive dyskinesia: association with plasma superoxide dismutase activity. Wu JQ; Chen DC; Tan YL; Tan SP; Wang ZR; Xiu MH; Yang FD; Zhang XY Schizophr Res; 2014 Jan; 152(1):210-6. PubMed ID: 24325977 [TBL] [Abstract][Full Text] [Related]
15. Association study between a functional glutathione S-transferase (GSTP1) gene polymorphism (Ile105Val) and tardive dyskinesia. Shinkai T; De Luca V; Hwang R; Matsumoto C; Hori H; Ohmori O; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Nakamura J; Kennedy JL Neurosci Lett; 2005 Nov; 388(2):116-20. PubMed ID: 16039055 [TBL] [Abstract][Full Text] [Related]
16. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs]. Seigneurie AS; Sauvanaud F; Limosin F Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134 [TBL] [Abstract][Full Text] [Related]
17. B vitamins attenuate haloperidol-induced orofacial dyskinesia in rats: possible involvement of antioxidant mechanisms. Macêdo DS; Oliveira GV; Gomes PX; Araújo FY; Souza CM; Vasconcelos SM; Viana GS; Sousa FC; Carvalho AF Behav Pharmacol; 2011 Oct; 22(7):674-80. PubMed ID: 21918383 [TBL] [Abstract][Full Text] [Related]
18. The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the Ala-9Val polymorphism. Zhang Z; Zhang X; Hou G; Sha W; Reynolds GP J Psychiatr Res; 2002; 36(5):317-24. PubMed ID: 12127599 [TBL] [Abstract][Full Text] [Related]
19. Tardive dyskinesia: Who gets it and why. Frei K Parkinsonism Relat Disord; 2019 Feb; 59():151-154. PubMed ID: 30522959 [TBL] [Abstract][Full Text] [Related]
20. Disrupted antioxidant enzyme activity and elevated lipid peroxidation products in schizophrenic patients with tardive dyskinesia. Zhang XY; Tan YL; Zhou DF; Cao LY; Wu GY; Haile CN; Kosten TA; Kosten TR J Clin Psychiatry; 2007 May; 68(5):754-60. PubMed ID: 17503985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]